Abstract
Melanoma cells are considered to be immunogenic because they express melanoma-associated antigens that are recognized by autologous T-cells. The role of T-lymphocytes in the host’s immune response to cancer in general and to melanoma in particular has been studied intensively during the past decade, and an immense amount of data have strengthened the notion that a functional and specific antimelanoma T-cell response operates in melanoma patients (1,2). This assumption has been strongly reinforced by the demonstration of clonotypic T-cells in both primary and metastatic melanoma (3,4). Nevertheless, the prognosis of metastatic melanoma is one of the most unfavorable in medicine. The coexistence of tumor-specific immunity with a progressing tumor remains a major paradox of tumor immunology and highlights the urgency to reveal new insights into the biology of antitumor T-cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albino, A. P., Reed, J. A., and McNutt, N. S. (1997) Malignant melanoma, in Cancer: Principle and Practice of Oncology (Devin, V. T., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 1935–1994.
Van den Eynde, B. J. and Boon, T. (1997) Tumor antigens recognized by T lymphocytes. Int. J. Clin. Lab. Res. 27, 81–86.
Pisarra, P., Mortarini, R., Salvi, S., Anichini, A., Parmiani, G., and Sensi, M. (1999) High frequency of T cell clonal expansions in primary human melanoma: involvement of a dominant clonotype in autologous tumor recognition. Cancer Immunol. Immunother. 48, 39–46.
thor Straten, P., Guldberg, P., Grønbæ, K., Zeuthen, J., and Becker, J. C. (1999) In situ T-cell responses against melanoma comprise high numbers of locally expanded t-cell clonotypes. J. Immunol. 163, 443-447.
thor Straten, P., Barfoed, A., Seremet, T., Saeterdal, I., Zeuthen, J., and Guldberg, P. (1998) Detection and Characterization of alpha/beta-T-cell Clonality by Denaturing Gradient Gel Electrophoresis (DGGE). Biotechniques 25, 244–250.
Myers, R. M., Maniatis, T., and Lerman, L. S. (1987) Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol. 155, 501–527.
Klebe, R. J., Grant, G. M., Grant, A. M., Garcia, M. A., Giambernardi, T. A., and Taylor, G.-P. (1996) RT-PCR without RNA isolation. Biotechniques 21, 1094–1100.
Yamamoto, K., Sakoda, H., Nakajima, T., Kato, T., Okubo, M., Dohi, M., Mizushima, Y., Ito, K., and Nishioka, K. (1992) Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int. Immunol. 4, 1219–1223.
Pannetier, C., Even, J., and Kourilsky, P. (1995) T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16, 176–181.
Becker, J. C., Guldberg, P., Zeuthen, J., Bröcker, E. B., and thor Straten, P. (1999) Accumulation of identical T cells in melanoma and vitiligo-like leukoderma. J. Invest. Dermatol. 113, 1033–1038.
thor Straten, P., Becker, J. C., Guldberg, P., and Zeuthen, J. (1999) In situ T cells in melanoma. Cancer Immunol. Immunother. 48, 386–395.
Barfoed, A., Reichert Petersen, T., Kirkin, A. F., thor Straten, P., Claesson, M.-H., and Zeuthen, J. (2000) Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365–73 wild type peptide loaded on dendritic cells in vitro, specifically recognise and lyse HLA-A2 tumour cells overexpressing the p53 protein. Scand. J. Immunol. 2, 128–133.
thor Straten, P., Guldberg, P., Seremet, T., Reisfeld, R. A., Zeuthen, J., and Becker, J. C. (1998) Activation of pre-existing T-cell clones by targeted interleukin 2 therapy. Proc. Natl. Acad. Sci. USA 95, 8785–8790.
thor Straten, P., Guldberg, P., Hald Andersen, M., Seremet, T., Siedel, C., Zeuthen, J., Reisfeld, R. A., and Becker, J. C. (1999) In situ cytokine therapy: redistribution of clonally expanded therapeutic T-cell clones, Eur. J. Immunol., in press.
Guldberg, P. and Gµttler, F. (1994) “Broad-range” DGGE for single-step mutation scanning of entire genes: application to human phenylalanine hydroxylase gene. Nucleic Acids Res. 22, 880–881.
Nedergaard, T., Guldberg, P., Ralfkiaer, E., and Zeuthen, J. (1997) A one step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-hodgkins lymphoma. Int. J. Cancer 71, 364–369.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Straten, P.t., Becker, J.C., Zeuthen, J., Guldberg, P. (2001). T-Cell Receptor Clonotype Mapping Using Denaturing Gradient Gel Electrophoresis. In: Nickoloff, B.J., Hood, L. (eds) Melanoma Techniques and Protocols. Methods in Molecular Medicine, vol 61. Humana Press. https://doi.org/10.1385/1-59259-145-0:339
Download citation
DOI: https://doi.org/10.1385/1-59259-145-0:339
Publisher Name: Humana Press
Print ISBN: 978-0-89603-684-0
Online ISBN: 978-1-59259-145-9
eBook Packages: Springer Protocols